Inducible T-Cell Co Stimulator Ligand (ICOSLG) Antibody (FITC)

Este producto es parte de ICOSLG - inducible T cell costimulator ligand
Product Graph
494€ (100 tests)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
Inducible T-Cell Co Stimulator Ligand (ICOSLG) Antibody (FITC)
category
Primary Antibodies
provider
Abbexa
reference
abx270369
tested applications
FCM

Description

Inducible T-Cell Co Stimulator Ligand (ICOSLG) Antibody (FITC) is a Rabbit Polyclonal Antibody conjugated to FITC against Inducible T-Cell Co Stimulator Ligand (ICOSLG) for use in flow cytometry.

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

CategoryPrimary Antibodies
Immunogen TargetInducible T-Cell Co Stimulator Ligand (ICOSLG)
HostRabbit
ReactivityHuman
Recommended DilutionFCM: 1-5 µl/106 cells. Optimal dilutions/concentrations should be determined by the end user.
ClonalityPolyclonal
ConjugationFITC
IsotypeIgG
PurificationPurified by antigen-specific affinity chromatography.
Size 1100 tests
Size 2200 tests
Size 3500 tests
FormLiquid
Tested ApplicationsFCM
Buffer0.01 M PBS, pH 7.4, containing 0.05% Proclin-300, 50% glycerol.
AvailabilityPlease enquire.
StorageAliquot and store at -20°C. Avoid exposure to light. Avoid repeated freeze/thaw cycles.
Dry IceNo
AliasICOS ligand, B7RP1,CD275,ICOSL,LICOS,B7RP-1,ICOS-L,IMD119,B7 homolog 2
BackgroundAntibody anti-ICOSLG
StatusRUO

Descripción

Inducible T-cell costimulator ligand (ICOSLG), also known as B7-H2 or CD275, is a critical immunoregulatory protein in the B7 family that provides costimulatory signals to T cells. ICOSLG serves as a ligand for ICOS (Inducible T-cell Costimulator), a receptor expressed on activated T cells. Through its interaction with ICOS, ICOSLG plays an essential role in modulating adaptive immune responses, particularly influencing T-cell differentiation, proliferation, and the formation of memory T cells. This interaction is crucial for both protective immunity and immune tolerance, enabling the immune system to respond robustly to pathogens while preventing autoimmunity. ICOSLG is primarily expressed on antigen-presenting cells (APCs), such as B cells, dendritic cells (DCs), macrophages, and certain epithelial cells in mucosal tissues. Its expression is inducible and can be upregulated during inflammation or immune activation by signals from pro-inflammatory cytokines like interferon-gamma (IFN-γ). The ICOS/ICOSLG axis is especially important for the regulation of germinal center formation in lymphoid tissues, where it facilitates B cell differentiation and antibody production. ICOSLG is also implicated in the maintenance of regulatory T cells (Tregs) and T-helper 17 (Th17) cells, thereby contributing to immune homeostasis and controlling inflammation.

Related Products

EH14691

Human ICOSLG(ICOS ligand) ELISA Kit

Ver Producto
EM0646

Mouse Icoslg(ICOS ligand) ELISA Kit

Ver Producto
FNab04111

anti- ICOSLG antibody

Ver Producto